Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Waterstone Pharmaceutical (wuhan) Co., Ltd.

Clinical trials sponsored by Waterstone Pharmaceutical (wuhan) Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for high potassium: phase 3 drug trial launches Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New hope for high potassium: phase 3 drug trial launches

Disease control Recruiting now

This study tests a new medicine called WS016 for people with high potassium levels (hyperkalemia). The trial has two parts: a short phase to quickly lower potassium, followed by a month-long phase to keep it in a safe range. About 420 adults with moderately high potassium will ta…

Phase 3 • Sponsor: Waterstone Pharmaceutical (Wuhan) Co., LTD. • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC